Bosco Elizalde, Author at ADL Biopharma

ADL BIOPHARMA GROWS BY 40% IN SALES AND MORE THAN DOUBLES ITS ECONOMIC RESULT

by Bosco Elizalde | Mar 23, 2023 | Media, Press

ADL Biopharma, leader in precision fermentation biotechnology production, announced today its results for the year 2022. Despite the challenging market conditions, the company reported an impressive 40% growth in sales, taking turnover to €53m. The vitality of sales...

Presentation of the Innovation Valley of Castilla y León

by Bosco Elizalde | Feb 23, 2023 | Press

Last Tuesday, the presentation of the Innovation Valley of Castilla y León took place in Burgos, where ADL Biopharma is of great importance due to its history, its capacity for innovation in food and personal care industries, and its industrial infrastructure. The...

ADL Biopharma attended the 3rd Fermentation-Enable Alternative Protein Summit

by Bosco Elizalde | Feb 16, 2023 | Press

ADL Biopharma attended the 3rd Fermentation-Enable Alternative Protein, an event in California that brings together the most important companies in the fermentation biotechnology sector. The 3 days of this outstanding event have been an opportunity for ADL to...

ADL BIOPHARMA GROWS BY 40% IN SALES AND MORE THAN DOUBLES ITS ECONOMIC RESULT

Presentation of the Innovation Valley of Castilla y León

ADL Biopharma attended the 3rd Fermentation-Enable Alternative Protein Summit

Recent Posts

Categories